Engineering a Mesoporous Silicon Nanoparticle Cage to Enhance Performance of a Phosphotriesterase Enzyme for Degradation of VX Nerve Agent
2024

Enhancing Enzyme Performance for VX Nerve Agent Degradation

publication 10 minutes Evidence: high

Author Information

Author(s): Lu Yi‐Sheng, Moreno Eduardo Reynoso, Huang Yubin, Fan Ruhan, Tucker Ashley T., Wright Linnzi K., Evans Ronald A., Ahern Brooke M., Owens Donald E., Chappell Stephen A., Christensen Dale J., Dresios John, Sailor Michael J.

Primary Institution: University of California San Diego

Hypothesis

Can a mesoporous silicon nanoparticle cage improve the performance of phosphotriesterase enzyme for degrading VX nerve agent?

Conclusion

The engineered enzyme@nanoparticle construct significantly enhances the degradation of VX nerve agent while maintaining enzyme stability and reusability.

Supporting Evidence

  • The enzyme@nanoparticle construct showed a two-fold increase in the rate of DMNP turnover compared to the free enzyme.
  • The nanoparticle cage retained hydrolysis activity through seven decontamination cycles.
  • The PTE@OxpSiNP construct demonstrated high activity toward VX in an ex vivo rabbit skin model.
  • The construct preserved acetylcholinesterase function when exposed to VX.

Takeaway

Scientists created a special cage for an enzyme that helps break down a dangerous nerve agent, making it work better and last longer.

Methodology

The study involved synthesizing a mesoporous silicon nanoparticle cage, loading it with the phosphotriesterase enzyme, and testing its catalytic performance against VX and a simulant.

Limitations

The study primarily focused on in vitro and ex vivo models, which may not fully represent in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1002/advs.202409535

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication